Social Anxiety Disorder (Sociale Angststoornis), Avoidant Personality Disorder (Ontwijkende Persoonlijkheidsstoornis)
Conditions
Interventions
1. The self-report version of the Liebowitz Social Anxiety Scale (LSAS-SR) will be used as primary outcome for social anxiety disorder. The LSAS-SR assesses the range of anxiety in social interaction
Sponsors
PsyQ en de Universiteit Leiden, afdeling klinische-, gezondheid- en neuropsychologie
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 18 and 65 with primary diagnoses of social anxiety disorder on axis I and comorbid avoidant personality disorder on axis-II (i.e. the principal focus of attention of treatment, according to both patient and clinical staff) will be included in the study. Other inclusion criteria are willingness, motivation and practical ability to attend 30 sessions of group therapy and to refrain from treatment or counseling outside the context of the present trial. The use of antidepressant medication or benzodiazepine will be permitted, under the condition that the medication dose has been stable for at least 3 months before inclusion and patients are willing not to change the dosage or change medication during the active phase of the trial. Furthermore, patients have to be willing to complete daily homework assignments between sessions and have to sign written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Changed 28-jun-2016: Exclusion criteria will be a Axis-I diagnosis of substance abuse or dependence which needs, according to the clinical staff, detoxification (after successful detoxification patients can participate), suicidality, and the presence of psychotic or bipolar symptoms because these conditions could interfere with the measurement and treatment procedures and suggest an immediate need for alternative interventions. Other exclusion criteria are: a primary Axis II diagnosis of a Borderline, antisocial, schizoid, schizotypal personality disorder (because they need highly specialized treatment), and IQ less than 80 (in case of suspicion an intelligence test is taken), suspicion of an autism spectrum disorder (based on the sum score on the Autisme-Spectrum Quotient (AQ) higher than 32 )and problems with Dutch language (talking, reading, writing).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Mini-International Neuropsychiatric Interview (MINI) will be used to obtain DSM-IV diagnoses for inclusion; 2. Structured Clinical Interview for DSM Axis II Disorders (SCID II) will be used to assess the presence versus absence of avoidant personality disorder and comorbid Axis II diagnoses; 3. The clinician-administered version of the Liebowitz Social Anxiety Scale (LSAS-CA) will be used to assess the range of anxiety in social interaction and performance in situations which patients with social anxiety disorder may fear. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Schema Mode Inventory II (SMI-2); 2. The social anxiety disorder section of the Mini International Neuropsychiatric Interview (MINI). 3. The avoidant personality disorder section of the Structured Clinical Interview for DSM Axis II Disorders (SCIDII) 4. Inventory of depressive symptomatology self-report (IDS-SR); 5. World Health Organization Quality of Life – Bref(WHOQOL-Bref); 6. Difficulties in Emotion Regulation Scale (DERS); 7. The Rosenberg Self-Esteem Scale (RSES); 8. Acceptance and Action Questionnaire (AAQ-II) | — |
Contacts
Public ContactAnja Greeven
PsyQ afdeling angststoornissen Lijnbaan 4
Outcome results
None listed